Las Vegas, NV -- (SBWIRE) -- 03/12/2013 -- Advaxis, Inc. (OTC:ADXS) announced that researchers of University of Pennsylvania working on ADXS-cHER2 Immunotherapy have received Penn One Health Award. Dr. Nicola Mason was the chief investigator of the Penn canine study along with scientific founder of Advaxis Dr. Yvonne Paterson.
The research team worked on treatment of canine osteosarcoma and got inaugural University of Pennsylvania One Health Award. Dr. Nicola Mason says that Phase 1 of the clinical trial is complete and it is great to find that there are no adverse effects of the treatment. Also he added that data shows that it will offer safer treatment for dogs with cancer.
AdvaxisInc operates in biotechnology industry and manufactures immunotherapies related to cancer and other diseases. Technology used by the company for treatment of HI is also under progress. Advaxis has effectively worked on immunotherapies for cancer types of prostate and HER2 expressing cancers. These HER2 expressing cancers include cancers of breast, bladder, brain, ovary and pancreas.
To find out what OTCMAGIC projects for Advaxis, Inc. for both short term and long term please click here: ADXS
OTCMAGIC Spends all day scouring the markets for the next huge Penny Stock Winner. Investors have come to trust us for our up to date commentary on all hot stocks so please visit OTCMAGIC right now and see what it’s all about for yourself! At 30,000 Visitors a Month and growing rapidly OTCMAGIC is the hottest thing in otc picks!
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PLEASE NOTE: OTCMagic.com employees are not registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at http://OTCMagic.com/disclaimer. Release of Liability: Through use of this website viewing or using you agree to hold OTCMagic.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss monetary or otherwise, damage monetary or otherwise, or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. OTCMagic.com affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTCMagic.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCMagic.com. We make no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. This is not a solicitation to buy or sell any securities. Any claims or Statements should be deemed hypothetical. OTCMagic.com, nor any of its affiliates are not registered investment advisors or broker dealers.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)